Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
04/02/2014 | EP2712617A1 Treatment of fibrosis using Fxr ligands |
04/02/2014 | EP2712616A1 N-carbonyl, 4-heterocyclyl substituted azocyclic compounds as fungicides |
04/02/2014 | EP2712615A1 Composition containing arylnaphthalene lignan derivative for preventing and/or treating dementia |
04/02/2014 | EP2712614A2 Solvating system and sealant for medical use |
04/02/2014 | EP2712613A1 Vitamin K1 and uses thereof |
04/02/2014 | EP2712611A1 Stabilized aqueous compositions of neuromuscular blocking agents |
04/02/2014 | EP2712610A1 Processes for making cyclic lipid implants for intraocular use |
04/02/2014 | EP2712358A2 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors |
04/02/2014 | EP2712317A1 Prevention of infection |
04/02/2014 | EP2712316A1 Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disorders |
04/02/2014 | EP2712315A1 Lysine demethylase inhibitors for myeloproliferative disorders |
04/02/2014 | EP2712291A1 N1- and n2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods |
04/02/2014 | CN1946395B 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
04/02/2014 | CN103703174A Combination pharmaceutical compositions and uses thereof |
04/02/2014 | CN103703014A Process for the production of estetrol intermediates |
04/02/2014 | CN103703008A (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists |
04/02/2014 | CN103703005A Tricyclic inhibitors of kinases |
04/02/2014 | CN103703004A Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as parp inhibitors |
04/02/2014 | CN103703002A Novel compound having parp inhibitory activity |
04/02/2014 | CN103703000A Fused tricyclic dual inhibitors of CDK 4/6 and FLT3 |
04/02/2014 | CN103702999A Cyclic p1 linkers as factor xia inhibitors |
04/02/2014 | CN103702996A Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives |
04/02/2014 | CN103702995A Polymorph form of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2h-pyran-4-carboxylic acid |
04/02/2014 | CN103702994A Phosphate esters of gyrase and topoisomerase inhibitors |
04/02/2014 | CN103702993A Benzamides |
04/02/2014 | CN103702991A Pyridin-2(1h)-one derivatives as jak inhibitors |
04/02/2014 | CN103702990A 2-(2,4,5-substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer |
04/02/2014 | CN103702989A Novel compounds as modulators of protein kinases |
04/02/2014 | CN103702985A Quinoxalines and aza-quinoxalines as crth2 receptor modulators |
04/02/2014 | CN103702984A N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists |
04/02/2014 | CN103702983A Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
04/02/2014 | CN103702982A Micronized crystals of atorvastatin hemicalcium |
04/02/2014 | CN103702980A Cyclic amine derivatives as EP4 receptor antagonists |
04/02/2014 | CN103702979A 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group |
04/02/2014 | CN103702975A Trans-clomiphene metabolites and uses thereof |
04/02/2014 | CN103702719A Novel fxr (nr1h4) binding and activity modulating compounds |
04/02/2014 | CN103702675A Rhus verniciflua stokes extract having increased content of active flavonoid compound and method for preparing same |
04/02/2014 | CN103702671A Materials for treating and preventing mucosa related disease |
04/02/2014 | CN103702670A Synthesis and use of glycoside pro-drug analogs |
04/02/2014 | CN103702669A Compounds for treating peripheral neuropathies and other neurodegenerative disorders |
04/02/2014 | CN103702668A Composition and method for treatment of diabetes |
04/02/2014 | CN103702667A Patch containing diclofenac and thiocolchicoside |
04/02/2014 | CN103702666A Levomilnacipran drug for functional rehabilitation after an acute neurological stroke |
04/02/2014 | CN103702665A Compounds for inflammation and immune-related uses |
04/02/2014 | CN103702664A Sustained release tablet comprising pregabalin through two-phase release-controlling system |
04/02/2014 | CN103702663A Formulations of amikacin and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis |
04/02/2014 | CN103702657A Use of a compound comprising at least one nucleophilic function for capturing carbonyl compounds resulting from the reaction between one or more compounds constituting sebum and ozone |
04/02/2014 | CN103702654A Use of a combination of carotenoid, phytoestrogen and vitamin c for the prevention and/or treatment of pigmentation disorders |
04/02/2014 | CN103702561A Opioid receptor ligands and methods of using and making same |
04/02/2014 | CN103702558A Melt processed antimicrobial composition |
04/02/2014 | CN103698515A Method for breaking aspergillus fumigatus biological film |
04/02/2014 | CN103695497A Enzymatic preparation of naloxone and pharmaceutical composition thereof |
04/02/2014 | CN103695368A Osteogenic differentiation inducer |
04/02/2014 | CN103694408A Preparation method of hydrophobically modified poly-cation chelating agent |
04/02/2014 | CN103694377A Amphiphilic C-6-(4-(methyl amino)-1,2,3-triazole)deoxidized inulin derivatives and preparation and application thereof |
04/02/2014 | CN103694375A Novel triterpene-cyclodextrin covalent compound and preparation method and use thereof |
04/02/2014 | CN103694367A Extraction and application methods of meretrix meretrix linnaeus polysaccharides with antioxidant activity |
04/02/2014 | CN103694303A Antitumor compound extracted from guttifer, and preparation method and application thereof |
04/02/2014 | CN103694302A Preparation method of 2 alpha, 3 beta-dihydroxyl-30-olea-12, 20(29)-diene-28-acid and application of 2 alpha, 3 beta-dihydroxyl-30-olea-12, 20(29)-diene-28-acid in preparing antitumor drug |
04/02/2014 | CN103694299A Steroid androgen receptor inhibitors and preparation method and medical application thereof |
04/02/2014 | CN103694258A Spiro-condensed 1, 3, 4-thiadiazole derivatives for inhibiting ksp kinesin activity |
04/02/2014 | CN103694254A Butene lactone compound containing sulfonyl lactones as well as synthesis method and application thereof |
04/02/2014 | CN103694252A Thienopyridine compound and anti-platelet aggregative activity thereof |
04/02/2014 | CN103694248A Antitumor compound extracted from guttifer, and preparation method and application thereof |
04/02/2014 | CN103694245A Crude medicine for hypoglycemic medicine |
04/02/2014 | CN103694244A 3, 6 substituted-1, 2, 4-triazole [3, 4-alpha] phthalazine compound as well as preparation method and application of 3, 6 substituted-1, 2, 4-triazole [3, 4-alpha] phthalazine compound |
04/02/2014 | CN103694242A Pyrazolopyrimidine compound and pharmaceutical composition thereof as well as pharmaceutical application of pyrazolopyrimidine compound |
04/02/2014 | CN103694240A Solvate of lixivaptan and preparation method and application thereof |
04/02/2014 | CN103694238A NO donor type matrine derivative and preparation method and medical application thereof |
04/02/2014 | CN103694236A Novel antineoplastic compound containing pyrimidine skeleton and hedgehog pathway antagonist activity |
04/02/2014 | CN103694234A Crystal form of dihydropyrimidine derivatives |
04/02/2014 | CN103694233A Benzisoxazole compound and application thereof |
04/02/2014 | CN103694218A Pyrimidine compound, PI3K inhibitor, pharmaceutical composition comprising PI3K inhibitor and application of inhibitor and pharmaceutical composition |
04/02/2014 | CN103694211A Pharmaceutical use of 2, 2-dimethyl chromanone type compound and analogs thereof |
04/02/2014 | CN103694209A Marine fungus-derived acetophenone compounds and preparation method and application thereof |
04/02/2014 | CN103694195A Heterocyclic aromatic micromolecule organic compounds and derivatives, preparation method and medical application |
04/02/2014 | CN103694185A Toltrazuril alkali metal salt as well as preparation method and application thereof |
04/02/2014 | CN103694172A Derivative of aza-aryl compound |
04/02/2014 | CN103694165A Gimeracil amorphous cured product and preparation method thereof |
04/02/2014 | CN103694163A Compounds capable of being adopted as potassium channel modulators |
04/02/2014 | CN103694133A Synthesis of laminine schiff base with anticancer activity and pharmaceutical composition thereof |
04/02/2014 | CN103694089A Mailuoning phenol and preparation method and application thereof |
04/02/2014 | CN103694084A Preparation method and application of menthol water-soluble compound |
04/02/2014 | CN103691357A Method for preparing anesthetic by utilizing system with thermostat and output device |
04/02/2014 | CN103691356A Method for preparing anesthetic by utilizing system with thermostat and recovery device |
04/02/2014 | CN103691355A Method for preparing anesthetic drug by system with recovery device and dovetail groove |
04/02/2014 | CN103690995A Bioabsorbable fiber, as well as preparation method and application thereof |
04/02/2014 | CN103690985A Incense formula capable of preventing cold |
04/02/2014 | CN103690975A Method of utilizing levocarnitine aqueous solution to produce trace 2(5H)-furanone, and measuring and application of trace 2(5H)-furanone |
04/02/2014 | CN103690968A Voriconazole composition and preparation method thereof |
04/02/2014 | CN103690967A Autonomous cattle feeding drug carrier and preparation method thereof |
04/02/2014 | CN103690966A Self-help-feeding drug carrier for chickens and preparation method thereof |
04/02/2014 | CN103690965A Self-help-feeding drug carrier for cats and preparation method thereof |
04/02/2014 | CN103690960A Lomitapide mesylate medicinal composition and preparation method thereof |
04/02/2014 | CN103690958A Insulin preparations containing methionine |
04/02/2014 | CN103690956A Hemostatic powder and preparation method thereof |
04/02/2014 | CN103690955A Ticagrelor-containing drug composition as well as preparation method and application thereof |
04/02/2014 | CN103690954A Cardiovascular protection medicinal composition and use thereof |
04/02/2014 | CN103690952A Compound drug for treating livestock and poultry escherichia coli infected diseases |
04/02/2014 | CN103690940A Compound dimetridazole premix for preventing and treating poultry enterovirus syndrome |